The Bioequivalence Study of Alfuzosin 10 mg Prolong-released Tablets Under Fed Conditions

Clinical trial NCT06228339 · UNKNOWN

Trial details

NCT number: NCT06228339
Sponsor: International Bio service
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer

Start date: 2024-03-09
Primary completion: 2024-03-14
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.